Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elingarami Sauli has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chitosan–hyaluronic acid engineered polycaprolactone nanoparticles enhance curcumin antiplasmodial activity and preserve blood–brain barrier integrity

    by James Mwajombe, Rami Ahmed, Retsepile E. Maphasa, Clarence Rubaka, Nateiya M. Yongolo, Mgeni Mohammed, Anneth Tumbo, Okobi Ekpo, Elingarami Sauli, Chontrelle Willemse, et al.

    Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection associated with endothelial activation, neuroinflammation, and disruption of the blood-brain barrier (BBB). While curcumin (Cur) possesses antiplasmodial and anti-inflammatory properties, its therapeutic potential is limited by poor aqueous solubility, rapid metabolism, and insufficient brain bioavailability. In this study, we hypothesized that polysaccharide-driven surface engineering could regulate nanoparticles (NPs) interfacial properties to improve BBB compatibility and antiplasmodial efficacy. Cur-loaded polycaprolactone (PCL) NPs were fabricated through a single-emulsion solvent evaporation technique and sequentially coated with chitosan (CS) and hyaluronic acid (HA) to establish defined structure-property relationships. The resulting nanoformulations were characterized for particle size, surface charge, polysaccharide deposition, encapsulation efficiency (EE), and release kinetics. In-vitro biological performance was evaluated through hemocompatibility, brain endothelial cell viability, BBB integrity through transendothelial electrical resistance measurements, and in-vitro antiplasmodial activity against P. falciparum FCR3. Dual polysaccharide coating produced stable NPs with controlled size, enhanced surface charge, sustained Cur release, and significantly improved endothelial compatibility compared with free Cur and non-hyaluronic-acid formulations. Notably, HA coating strengthened BBB integrity and enhanced antiplasmodial potency. These findings demonstrate that CS- HA surface functionalization governs critical structure-property relationships, highlighting the potential of polysaccharide-engineered nanocarriers for adjunctive CM drug delivery.


  • Open Access

    Micronutrient Status and Psychosocial Risk Factors Associated with Depressive Symptoms Among the Elderly in Zanzibar

    by Mosi Khalfan Machano, Clara Justine Mollay, Emmanuel Abraham Mpolya, Elingarami Sauli

    Micronutrient deficiencies and depression are prevalent issues among older adults. The purpose of this study was to investigate the connection between depressive symptoms and micronutrient status in the Zanzibar population.A total of 245 respondents from Zanzibar’s urban municipality were randomly selected. The Geriatric Depression Scale Short Form was used to determine depression levels. In contrast, plasma levels of zinc and vitamin C were assessed via an Atomic Absorption Spectrophotometer and a UV/Vis/IR spectrophotometer, respectively. Data analysis included univariate, bivariate, and multivariate (using modified Poisson regression) methods. Depression prevalence was 32.65%, with zinc deficiency at 78.37% and vitamin C deficiency at 28.98%. A significant association was found between low zinc levels and depression (APR = 6.931, p = 0.0019), no association was noted for vitamin C. Additional factors linked to depression included low education, adverse life events, and moderate social support. This study highlights the importance of zinc in mental health among older adults in Zanzibar, underscoring the need for cohort and clinical trial research.

  • Heparin-functionalized chitosan-poly(ε-caprolactone) nanoparticles loaded with quinine for selective targeting of infected erythrocytes and enhanced antiplasmodial efficacy

    by Yohana Amos, Rami Ahmed, Elingarami Sauli, Clarence Rubaka, Mgeni Mohammed Tambwe, Anneth Tumbo, Hulda Swai, Admire Dube

    Malaria remains a major global health burden, particularly in sub-Saharan Africa. Although quinine (QN) is an effective antimalarial, its clinical application is limited by dose-dependent toxicity from nonspecific biodistribution. This study developed heparin-functionalized PCL nanoparticles (Hep-QN-PCL) to target Plasmodium falciparum-infected RBCs and enhance QN's therapeutic efficacy. QN-loaded PCL nanoparticles were formulated using a double emulsion solvent evaporation technique, followed by chitosan-mediated heparin conjugation. They were evaluated for physicochemical properties, in vitro drug release, hemolysis, cytotoxicity, targeting, and antiplasmodial activity against FCR3 Plasmodium falciparum. Optimized Hep-QN-PCL nanoparticles (353.2 ± 16.8 nm, PDI 0.252, zeta +20.8 ± 1.9 mV, encapsulation 77.9%) showed successful Hep conjugation as confirmed through FTIR and thermal analysis, sustained QN release over 96 h via Fickian diffusion, and enhanced release under iRBC-mimicking conditions. They were hemocompatible (527 µg/mL vs. 195.7 µg/mL for free QN), and demonstrated increased iRBC targeting (partition 8.50 ± 0.30 vs. 4.20 ± 0.12). Hep-QN-PCL achieved ~5.3-fold higher antiplasmodial potency (IC50 = 23.33 ng/mL vs. 122.86 ng/mL) and 14.2-fold greater selectivity index (22.60 vs. 1.59). These findings demonstrate a targeted nanomedicine platform with improved efficacy and safety for malaria therapy, suitable for further preclinical studies.

  • Open Access

    Transfer of polonium-210 from soil to tobacco oroducts and their associated radiological dose to smokers in Tanzania

    by Nurjed Sadick Issa, Elingarami Sauli Nkya, Shovi Furaeli Sawe, Ruth Lorivi Moirana

    This study investigated the transfer of polonium-210 (210Po) from soil to tobacco products and the associated radiological risks to smokers. Soil, tobacco leaf, and cigarette samples were collected from three major tobacco-growing regions, Iringa (Magubike), Tabora (Sikonge), and Ruvuma...

  • Top Cited Papers
    Open Access

    Botanical Adjuvants in Oncology: A Review on Natural Compounds in Synergy with Conventional Therapies as Next-Generation Enhancers of Breast Cancer Treatment

    by Hidaya Mansouri, Ahmed Irchad, Clarence Rubaka, Lydia Kisula, Abdou Azali Hamza, Elingarami Sauli

    Breast cancer remains a major global health challenge despite advances in chemotherapy, endocrine therapy, targeted therapy, and radiotherapy, which are frequently constrained by therapeutic resistance, cumulative toxicity, and high costs. Accumulating preclinical and translational evidence demonstrates that plant-derived natural compounds can synergistically enhance the efficacy of conventional treatments, improve tumor response, and potentially reduce adverse effects. This review critically synthesizes in vitro, in vivo, and emerging clinical studies from 2015 to 2025, focusing on key phytochemicals, including curcumin, epigallocatechin-3-gallate, resveratrol, kaempferol, genistein, and other bioactive molecules as stand alone agents and as mechanistically validated adjuvants to chemotherapy, hormonal therapy, and radiotherapy. These compounds exert complementary actions, including the inhibition of PI3K/Akt/mTOR and NF-κB signaling, induction of apoptosis and cell-cycle arrest, suppression of epithelial–mesenchymal transition, and modulation of drug resistance pathways. Preclinical studies consistently show that combination strategies enhance tumor inhibition and may permit cytotoxic dose reduction, mitigating systemic and cardiotoxic effects. Nanocarrier-based delivery systems further optimize solubility, bioavailability, and tumor targeting. Despite robust preclinical evidence, clinical translation is limited by variability in raw materials, lack of standardization, regulatory barriers, and scarce large-scale trials. This review emphasizes both the therapeutic promise and translational challenges of integrating natural compounds as synergistic adjuvants in evidence-based breast cancer therapy.


  • Open Access

    Osteogenic Differentiation Properties of BLGFs/ODEX Hydrogel Doped With Collagen Derived From Chambo tilapia Fish Skin

    by Bhahat Lawlley Zimba, Xiaohan Yang, Mwemezi Rwiza, Elingarami Sauli, Shenqi Wang

    Background: Bone defects caused by trauma, congenital disorders and degenerative diseases such as osteoporosis remain a major clinical challenge, especially in developing regions. Although bone grafting is the current gold standard for treating bone defects, it faces limitations, including donor site morbidity, limited availability and immune rejection. This study developed and evaluated a novel hybrid biomaterial composed of bovine β‐lactoglobulin fibrils (BLGFs), oxidized dextran (ODEX) and collagen (COL) extracted from Chambo tilapia fish skin for bone tissue engineering applications. Methods: BLGFs were synthesized from whey protein, while ODEX was produced by oxidizing dextran. Three biomaterials–COL, BLGFs/ODEX and BLGFs/ODEX/COL–were synthesized and characterized using Fourier‐transformed infrared (FTIR), scanning electron microscope (SEM), and X‐ray diffraction (XRD). Cytocompatibility and haemocompatibility were assessed through MTT and haemolysis assays using rat red blood cells. Osteogenic potential was evaluated by Alizarin Red staining after culturing rat bone marrow stem cells in osteoinduction media. Results: The BLGFs/ODEX/COL hydrogel exhibited better porosity, biocompatibility and mechanical stability. SEM and MTT results confirmed robust cell adhesion, spreading, and viability, while haemolysis rates remained below 5%. Enhanced calcium deposition in rBMSCs indicated strong osteogenic differentiation. These results demonstrate that the BLGFs/ODEX/COL hydrogel is a promising, affordable, and biocompatible scaffold for bone tissue regeneration.

  • Open Access

    Phytochemical Composition, Toxicity, and in vivo Antimicrobial Properties of Euphorbia hirta and Plectranthus barbatus Ethanolic Extracts’ Polyherbal Formulation

    by Optatus Mwalongo, Lydia Kisula, David Credo, Elingarami Sauli

    Background: Tanzanian communities use a herbal mixture of Euphorbia hirta and Plectranthus barbatus as a decoction to treat several diseases, including respiratory disorders, infertility, urinary tract infections (UTIs), dysmenorrhoea, and pelvic inflammatory disease. Despite its potential health benefits, there is a paucity of information regarding its safety and efficacy. Objectives: This study examined the phytochemical profiles, acute and sub-acute oral toxicity of 1:1 (w/w) extract mixture of E. hirta and P. barbatus (EP), and evaluated the in vivo antimicrobial efficacy of the EP polyherbal formulation in albino mice and Wistar rats. Methods: Phytochemical analysis of E. hirta and P. barbatus extracts, as well as the polyherbal formulation, was performed using Gas Chromatography-Mass Spectrometry (GC-MS), Liquid chromatography-Mass spectrometry (LC-MS), and Fourier Transform Infrared Spectroscopy (FTIR), respectively. The toxicity testing was conducted in accordance with Organisation for Economic Co-operation and Development (OECD) guidelines 423 and 407. Subsequently, the in vivo efficacy against Escherichia coli American Type culture Collection (ATCC) 25922 and Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 43300 was tested at doses of 50, 150, and 450 mg/kg in infected Wistar rats. Results: E. hirta and P. barbatus extracts each contained 29 and 24 bioactive compounds, respectively, with known antimicrobial properties. In the acute toxicity test, the Lethal Dose 50% (LD 50 ) of the EP was over 2000 mg/kg. The sub-acute toxicity assessment showed mild morphological changes in the liver and kidneys of Wistar rats at a dose of 1000 mg/kg. However, there were no significant differences in haematological and biochemical parameters between the treatment and control groups. Additionally, the in vivo polyherbal formulation efficacy cleared the E.coli and MRSA loads at dose of 150 mg/kg by the eighth and 14 th days of the test for E. coli and MRSA, respectively. Conclusion: The polyherbal formulation demonstrates promising therapeutic efficacy and considered safe up to 500 mg/kg when administered repeatedly over 28 days.

  • Open Access

    Clinical application of Chambo tilapia fish skin xenograft for skin tissue regeneration: A case report in a partial-thickness burns pediatric patient

    by Bhahat Lawlley Zimba, Dennis Mtunduwatha, David Hara, Mukondwedi Mchazime, Aaron Stima, Mwemezi Rwiza, Elingarami Sauli